2

2invest

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

2invest AG is a listed company that acquires, holds, manages, and sells investments in corporations and partnerships.

Investor Profile

2invest has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 33% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United Kingdom, Italy.
  • Strong thematic focus on Biotechnology, Simulation, Therapeutics.

Stage Focus

  • Series B (100%)

Country Focus

  • United Kingdom (67%)
  • Italy (33%)

Industry Focus

  • Biotechnology
  • Simulation
  • Therapeutics
  • Translation Service
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 2invest frequently co-invest with?

Claris Ventures
Europe, Piemonte, Italy, Torino
Co-Investments: 3
LIFTT
Europe, Piemonte, Italy, Turin
Co-Investments: 1
Sixth Element Capital
Europe, Buckinghamshire, United Kingdom, Berkhamsted
Co-Investments: 2
SF
Europe, Piemonte, Italy, Turin
Co-Investments: 1
3B Future Health Fund
Europe, Bayern, Germany, Monaco
Co-Investments: 3
A6
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Neva SGR
Europe, Piemonte, Italy, Turin
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 2
Ace Ventures
Europe, Brandenburg, Germany, Potsdam
Co-Investments: 1
CDP Venture Capital
Europe, Lazio, Italy, Rome
Co-Investments: 1

What are some of recent deals done by 2invest?

NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BFeb 1, 2024
Amount Raised: $12,236,423
NeoPhore

Cambridge, Cambridgeshire, United Kingdom

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

BiotechnologySimulationTherapeuticsTranslation Service
Series BJan 19, 2023
Amount Raised: $7,435,460
Kither Biotech

Torino, Piemonte, Italy

Kither Biotech is a pharmaceutical product company that developmens of new drugs to treat chronic inflammatory diseases

BiopharmaBiotechnologyLife Science
Series BMar 16, 2022
Amount Raised: $20,390,124